Fundraising Fox

John Maraganore

Investor

Advisor at Oak HC/FT

Boston, Massachusetts, United States

About

Founding CEO of Alnylam Pharmaceuticals, which he led from 2002-2021, overseeing the development and commercialization of the first RNAi medicines. He is currently CEO of JMM Innovations and serves on numerous biopharma boards; he holds an M.S. and Ph.D. in biochemistry and molecular biology from the University of Chicago.

LinkedIn ↗

Experience

  1. Corsera HealthCo-Chief Executive Officercurrent2025 — presentBoston, Massachusetts, United States
  2. Merida BiosciencesBoard Membercurrent2025 — present
  3. JEFFRIES FINANCIAL SERVICES LTDSenior Business Advisorcurrent2024 — presentNew York City Metropolitan Area
  4. City TherapeuticsExecutive Chaircurrent2023 — present
  5. Omega FundsVenture Partnercurrent2022 — present
  6. TakedaBoard Membercurrent2022 — present
  7. Kymera TherapeuticsBoard Membercurrent2022 — present
  8. Hemab TherapeuticsChairperson of the Boardcurrent2022 — present
  9. BlackstoneExecutive Advisorcurrent2022 — presentBoston, Massachusetts, United States
  10. Atlas VentureVenture Partnercurrent2022 — presentCambridge, Massachusetts, United States
  11. JMM Innovations LLCPrincipal CEOcurrent2022 — presentBoston, Massachusetts, United States
  12. BeamBoard Membercurrent2021 — present
  13. RTW Investments, LPExecutive Partnercurrent2022 — presentBoston, Massachusetts, United States
  14. Aera TherapeuticsChairperson of the Boardcurrent2022 — present
  15. ARCH Venture PartnersVenture Partnercurrent2021 — presentBoston, Massachusetts, United States
  16. Biotechnology Innovation OrganizationBoard Membercurrent2006 — present
  17. Biotechnology Innovation OrganizationChairperson of the Board2017 — 2019
  18. Rapport TherapeuticsBoard Member2024 — 2025
  19. Orbital TherapeuticsChairperson of the Board2023 — 2025
  20. VersanisBoard Member2022 — 2023

Education

  1. University of ChicagoPh.D., Department of Biochemistry and Molecular Biology
  2. University of ChicagoM.S., Department of Biochemistry and Molecular Biology
  3. University of ChicagoB.A., Division of Biological Sciences

Same school

Also attended University of Chicago273

Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalJonas CiplickasPrincipal at Scale Venture PartnersJulia Gonzalez SandersPartner and General Counsel at Crosslink Capital

+ 267 more

Shared employers

Also worked at Merida Biosciences2

Reid HuberPartner at Third Rock VenturesDrew FieldPrincipal at Bain Capital Life Sciences

Also worked at City Therapeutics1

Sebastian TrousilPrincipal at RTW Investments L.P.

Also worked at Kymera Therapeutics4

Richard ChesworthInvestor at Third Rock VenturesPeter DudekPresident at MRL Ventures FundWei LiGeneral Partner at 6 Dimensions CapitalChristopher O'DonnellPartner at Pfizer Venture Investments

Also worked at Atlas Venture52

Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesKristen LaguerreExecutive Partner at MPM BioImpactKate GunioController at Long Ridge Equity PartnersHenri MoissinacInvestor at FELIX CAPITALPeter BarrettPartner Legacy Funds at Atlas Venture

+ 46 more

Colleagues at Oak HC/FT

Alana Bremner
Director of Marketing & Communications at Oak HC/FT
Allen Miller
Partner at Oak HC/FT
Alli Kinzel
Marketing Administrative Coordinator at Oak HC/FT
Amit Jhawar
Advisor at Oak HC/FT
Andrew Adams
Co-Founder and Managing Partner at Oak HC/FT
Andrew Smith
Partner at Oak HC/FT
Anil Aggarwal
Venture Partner at Oak HC/FT
Annie Lamont
Co-Founder and Managing Partner at Oak HC/FT